The rising prevalence in GLP-1 agonists for weight control has led to a debate about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 therapies were solely available in pill https://nettiehhnl002982.blue-blogs.com/49138823/glp-1-transdermal-delivery-systems-vs-pills-which-right-for-you